Episode 40. Management of Newly Diagnosed AL Amyloidosis with Dr. Angela Dispenzieri

In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. 

Here are the key articles discussed:

1.      Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/

 

2.     Mayo 2004 staging:  https://pubmed.ncbi.nlm.nih.gov/15365071/

 

3.     Mayo 2012 staging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675680/

 

4.     Renal staging: https://pubmed.ncbi.nlm.nih.gov/25115890/

 

5.     Hematologic and cardiac response criteria in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/23091105/

 

6.     ANDROMEDA Trial: Dara-VCD vs VCD in newly diagnosed AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34192431/

 

7.      How I Treat AL Amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34517412/

 

8.     Venetoclax in AL amyloidosis (largest retrospective study till date): 

https://pubmed.ncbi.nlm.nih.gov/33431806/

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk